Hematological Malignancies

Showing NaN - NaN of 9

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Hematological Malignancies Trial in Worldwide (Teclistamab)

Recruiting
  • Hematological Malignancies
  • Birmingham, Alabama
  • +80 more
Jan 27, 2023

Hematological Malignancies Trial in United Kingdom, United States (Magrolimab, Azacitidine)

Active, not recruiting
  • Hematological Malignancies
  • Duarte, California
  • +26 more
Dec 7, 2022

Pediatric Cancer, Solid Tumor Pediatric, Hematological Malignancies Trial in Worldwide (Durvalumab / Tremelimumab Combination

Active, not recruiting
  • Pediatric Cancer
  • +2 more
  • Durvalumab / Tremelimumab Combination Therapy
  • Baltimore, Maryland
  • +18 more
Nov 3, 2022

MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular

Recruiting
  • Monoclonal Gammopathy of Undetermined Significance (MGUS)
  • +8 more
    • Boston, Massachusetts
    • +6 more
    Apr 14, 2022

    Hematological Malignancies Trial in Boston, Durham (Pasireotide)

    Completed
    • Hematological Malignancies
    • Boston, Massachusetts
    • +1 more
    Oct 19, 2021

    Hematological Malignancies Trial in Canada, Denmark, United States (KPT-330)

    Completed
    • Hematological Malignancies
    • Tampa, Florida
    • +11 more
    Mar 5, 2021

    Hematological Malignancies, Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML) Trial in Worldwide (NiCord®

    Active, not recruiting
    • Hematological Malignancies
    • +6 more
    • NiCord® (omidubicel)
    • Cord Blood Unit
    • Los Angeles, California
    • +51 more
    Jan 7, 2021

    Hematological Malignancies Trial in Boston (Rituximab, 375 mg/m2 RRituximab)

    Completed
    • Hematological Malignancies
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    Feb 3, 2014

    Hematological Malignancies, Leukemia, Lymphoma Trial in United States (STA-5312)

    Completed
    • Hematological Malignancies
    • +3 more
    • Pamona, California
    • +7 more
    Dec 3, 2008